The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial
(2008) In Antimicrobial Agents and Chemotherapy 52(7). p.2599-2607- Abstract
Granulocyte chemotactic protein 2 (GCP-2)/CXCL6 is a CXC chemokine expressed by macrophages and epithelial and mesenchymal cells during inflammation. Through binding and activation of its receptors (CXCR1 and CXCR2), it exerts neutrophil-activating and angiogenic activities. Here we show that GCP-2/CXCL6 itself is antibacterial. Antibacterial activity against gram-positive and gram-negative pathogenic bacteria of relevance to mucosal infections was seen at submicromolar concentrations (minimal bactericidal concentration at which 50% of strains tested were killed, 0.063 +/- 0.01 to 0.37 +/- 0.03 muM). In killed bacteria, GCP-2/CXCL6 associated with bacterial surfaces, which showed membrane disruption and leakage. A structural prediction... (More)
Granulocyte chemotactic protein 2 (GCP-2)/CXCL6 is a CXC chemokine expressed by macrophages and epithelial and mesenchymal cells during inflammation. Through binding and activation of its receptors (CXCR1 and CXCR2), it exerts neutrophil-activating and angiogenic activities. Here we show that GCP-2/CXCL6 itself is antibacterial. Antibacterial activity against gram-positive and gram-negative pathogenic bacteria of relevance to mucosal infections was seen at submicromolar concentrations (minimal bactericidal concentration at which 50% of strains tested were killed, 0.063 +/- 0.01 to 0.37 +/- 0.03 muM). In killed bacteria, GCP-2/CXCL6 associated with bacterial surfaces, which showed membrane disruption and leakage. A structural prediction indicated the presence of three antiparallel NH(2)-terminal beta-sheets and a short amphipathic COOH-terminal alpha-helix; the latter feature is typical of antimicrobial peptides. However, when the synthetic derivatives corresponding to the NH(2)-terminal (50 amino acids) and COOH-terminal (19 amino acids, corresponding to the putative alpha-helix) regions were compared, higher antibacterial activity was observed for the NH(2)-terminus-derived peptide, indicating that the holopeptide is necessary for full antibacterial activity. An artificial model of bacterial membranes confirmed these findings. The helical content of GCP-2/CXCL6 in the presence or absence of lipopolysaccharide or negatively charged membranes was studied by circular dichroism. As with many antibacterial peptides, membrane disruption by GCP-2/CXCL6 was dose-dependently reduced in the presence of NaCl, which, we here demonstrate, inhibited the binding of the peptide to the bacterial surface. Compared with CXC chemokines ENA-78/CXCL5 and NAP-2/CXCL7, GCP-2/CXCL6 showed a 90-fold-higher antibacterial activity. Taken together, GCP/CXCL6, in addition to its chemotactic and angiogenic properties, is likely to contribute to direct antibacterial activity during localized infection.
(Less)
- author
- Linge, Helena M LU ; Collin, Mattias LU ; Nordenfelt, Pontus LU ; Mörgelin, Matthias LU ; Malmsten, Martin LU and Egesten, Arne LU
- organization
- publishing date
- 2008-07
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Amino Acid Sequence, Anti-Bacterial Agents, Antimicrobial Cationic Peptides, Blood Bactericidal Activity, Cell Membrane, Chemokine CXCL5, Chemokine CXCL6, Escherichia coli, Gram-Negative Bacteria, Gram-Positive Bacteria, Humans, In Vitro Techniques, Liposomes, Microbial Sensitivity Tests, Models, Molecular, Protein Structure, Secondary, Recombinant Proteins, Staphylococcus aureus, Streptococcus pyogenes, beta-Thromboglobulin, Journal Article, Research Support, Non-U.S. Gov't
- in
- Antimicrobial Agents and Chemotherapy
- volume
- 52
- issue
- 7
- pages
- 9 pages
- publisher
- American Society for Microbiology
- external identifiers
-
- wos:000257183400042
- pmid:18443119
- scopus:46249102418
- pmid:18443119
- ISSN
- 1098-6596
- DOI
- 10.1128/AAC.00028-08
- language
- English
- LU publication?
- yes
- id
- 1ea89df9-6551-48ce-ab60-2620d6211255 (old id 1154702)
- alternative location
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2443903/
- date added to LUP
- 2016-04-04 09:18:42
- date last changed
- 2022-01-29 17:16:56
@article{1ea89df9-6551-48ce-ab60-2620d6211255, abstract = {{<p>Granulocyte chemotactic protein 2 (GCP-2)/CXCL6 is a CXC chemokine expressed by macrophages and epithelial and mesenchymal cells during inflammation. Through binding and activation of its receptors (CXCR1 and CXCR2), it exerts neutrophil-activating and angiogenic activities. Here we show that GCP-2/CXCL6 itself is antibacterial. Antibacterial activity against gram-positive and gram-negative pathogenic bacteria of relevance to mucosal infections was seen at submicromolar concentrations (minimal bactericidal concentration at which 50% of strains tested were killed, 0.063 +/- 0.01 to 0.37 +/- 0.03 muM). In killed bacteria, GCP-2/CXCL6 associated with bacterial surfaces, which showed membrane disruption and leakage. A structural prediction indicated the presence of three antiparallel NH(2)-terminal beta-sheets and a short amphipathic COOH-terminal alpha-helix; the latter feature is typical of antimicrobial peptides. However, when the synthetic derivatives corresponding to the NH(2)-terminal (50 amino acids) and COOH-terminal (19 amino acids, corresponding to the putative alpha-helix) regions were compared, higher antibacterial activity was observed for the NH(2)-terminus-derived peptide, indicating that the holopeptide is necessary for full antibacterial activity. An artificial model of bacterial membranes confirmed these findings. The helical content of GCP-2/CXCL6 in the presence or absence of lipopolysaccharide or negatively charged membranes was studied by circular dichroism. As with many antibacterial peptides, membrane disruption by GCP-2/CXCL6 was dose-dependently reduced in the presence of NaCl, which, we here demonstrate, inhibited the binding of the peptide to the bacterial surface. Compared with CXC chemokines ENA-78/CXCL5 and NAP-2/CXCL7, GCP-2/CXCL6 showed a 90-fold-higher antibacterial activity. Taken together, GCP/CXCL6, in addition to its chemotactic and angiogenic properties, is likely to contribute to direct antibacterial activity during localized infection.</p>}}, author = {{Linge, Helena M and Collin, Mattias and Nordenfelt, Pontus and Mörgelin, Matthias and Malmsten, Martin and Egesten, Arne}}, issn = {{1098-6596}}, keywords = {{Amino Acid Sequence; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Blood Bactericidal Activity; Cell Membrane; Chemokine CXCL5; Chemokine CXCL6; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Liposomes; Microbial Sensitivity Tests; Models, Molecular; Protein Structure, Secondary; Recombinant Proteins; Staphylococcus aureus; Streptococcus pyogenes; beta-Thromboglobulin; Journal Article; Research Support, Non-U.S. Gov't}}, language = {{eng}}, number = {{7}}, pages = {{2599--2607}}, publisher = {{American Society for Microbiology}}, series = {{Antimicrobial Agents and Chemotherapy}}, title = {{The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial}}, url = {{http://dx.doi.org/10.1128/AAC.00028-08}}, doi = {{10.1128/AAC.00028-08}}, volume = {{52}}, year = {{2008}}, }